ZA879593B - Nasal solutions - Google Patents

Nasal solutions

Info

Publication number
ZA879593B
ZA879593B ZA879593A ZA879593A ZA879593B ZA 879593 B ZA879593 B ZA 879593B ZA 879593 A ZA879593 A ZA 879593A ZA 879593 A ZA879593 A ZA 879593A ZA 879593 B ZA879593 B ZA 879593B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
human calcitonin
nasal solutions
meterable
derivative
Prior art date
Application number
ZA879593A
Other languages
English (en)
Inventor
Geller Leo
Glanzmann Peter
Original Assignee
Ciba-Geigy Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba-Geigy Ag. filed Critical Ciba-Geigy Ag.
Publication of ZA879593B publication Critical patent/ZA879593B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA879593A 1986-12-23 1987-12-22 Nasal solutions ZA879593B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH520086 1986-12-23

Publications (1)

Publication Number Publication Date
ZA879593B true ZA879593B (en) 1988-06-22

Family

ID=4289609

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879593A ZA879593B (en) 1986-12-23 1987-12-22 Nasal solutions

Country Status (15)

Country Link
EP (1) EP0277462B1 (da)
JP (1) JPS63166832A (da)
AT (1) ATE75404T1 (da)
AU (1) AU608268B2 (da)
CA (1) CA1322330C (da)
DE (1) DE3778682D1 (da)
DK (1) DK166714B1 (da)
ES (1) ES2032303T3 (da)
GR (1) GR3004585T3 (da)
IL (1) IL84861A (da)
MY (1) MY102411A (da)
NZ (1) NZ223005A (da)
PH (1) PH24802A (da)
PT (1) PT86436B (da)
ZA (1) ZA879593B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
AU638128B2 (en) * 1990-04-10 1993-06-17 University Of Melbourne, The Calcitonin gene related peptide for the treatment of undescended testicles
CA2080354A1 (en) * 1990-04-10 1991-10-11 John M. Hutson Calcitonin gene related peptide for the treatment of undescended testicles
JP3179538B2 (ja) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト 安定なヒトカルシトニンの水性溶液
GB9108634D0 (en) * 1991-04-23 1991-06-12 Ciba Geigy Pharmaceutical compositions
EP0803255A4 (en) * 1994-06-03 1999-06-30 Tsumura & Co DRUG
PT1051155E (pt) * 1998-01-30 2002-10-31 Novartis Consumer Health Sa Solucoes nasais
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
JP2002154989A (ja) * 2000-11-14 2002-05-28 Lion Corp 眼科用組成物、及び生体粘膜への薬物の滞留性向上組成物
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
CH657858A5 (de) * 1983-06-27 1986-09-30 Ciba Geigy Ag Substanz aus der gruppe der calcitonine.
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物

Also Published As

Publication number Publication date
NZ223005A (en) 1990-07-26
DK676987D0 (da) 1987-12-22
DK676987A (da) 1988-06-24
ES2032303T3 (es) 1993-02-01
CA1322330C (en) 1993-09-21
PT86436B (pt) 1990-11-20
DE3778682D1 (de) 1992-06-04
DK166714B1 (da) 1993-07-05
GR3004585T3 (da) 1993-04-28
EP0277462A1 (de) 1988-08-10
PT86436A (en) 1988-01-01
AU608268B2 (en) 1991-03-28
PH24802A (en) 1990-10-30
IL84861A (en) 1992-09-06
EP0277462B1 (de) 1992-04-29
ATE75404T1 (de) 1992-05-15
AU8295587A (en) 1988-06-23
JPS63166832A (ja) 1988-07-11
MY102411A (en) 1992-06-17

Similar Documents

Publication Publication Date Title
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
EP0552256A4 (da)
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
MY101026A (en) An improved method for administering insulin.
EP0252227A3 (en) Use of inositol triphosphate in the treatment of metal intoxication
MY101784A (en) Novel pharmacological compounds
GR3004585T3 (da)
HK55896A (en) Pharmaceutical composition comprising 3'-deoxythymidin-2'-ene (3'-deoxy-2' 3'-didehydrothymidine) in treating patients infected with retrovirus
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
ATE56138T1 (de) Perfluorkohlenwasserstoffe als vehikel zur verabreichung von arzneimitteln.
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
ZA876411B (en) A substance or composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-dideoxy-2',3'-didehydrocytidine)for use in treating patients infected with retroviruses
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
JPS5551019A (en) Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
IL76458A0 (en) Polyether ionophore,its preparation and pharmaceutical and veterinary preparations containing it
ES2029161A6 (es) Procedimiento para la preparacion de composiciones de carbocisteinato de zinc.
JO1531B1 (en) New near-compounds
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.